MSB 0.91% $1.11 mesoblast limited

Novartis - Heart Failure - Primary Endpoints, page-89

  1. 307 Posts.
    lightbulb Created with Sketch. 76
    The more I read into this the more I'm for Novartis buy out, might be the only way MSBs products hit the market
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.